Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review 2024

News provided by

Mar 01, 2024, 12:00 ET

DUBLIN, March 1, 2024 /PRNewswire/ -- The "Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.

The clinical trial report provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Post-Traumatic Stress Disorder (PTSD) and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

Report Scope

The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months

Key Benefits

Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level

Key Topics Covered:

Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Post-Traumatic Stress Disorder (PTSD) to Central Nervous System Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Post-Traumatic Stress Disorder (PTSD) to Central Nervous System Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Post-Traumatic Stress Disorder (PTSD) Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots

Company Coverage

Multidisciplinary Association for Psychedelic studies
GSK plc
The Lundbeck Foundation
Johnson & Johnson
Otsuka Holdings Co Ltd
Tonix Pharmaceuticals Holding Corp
Bionomics Ltd
Pfizer Inc
Premier Research Holdings Inc
Thermo Fisher Scientific Inc

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/1sm7ru

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets